SNAP Update and ResourcesActualización y recursos de SNAP
On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more
El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más
Transportation UpdateActualización de transporte
Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines Removed From Formulary on April 21, 2023
Date: May 8, 2023
Attention: All Providers
Effective Date: April 21, 2023
Call to action: Texas Children Health Plan (TCHP) would like to inform providers that effective April 21, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This is to simplify the vaccination schedule for most individual vaccines, and monovalent are no longer authorized for use in the United States.
This announcement includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals six months and older, including for an additional dose or doses for specific populations.
How this impacts providers: HHSC removed the following monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines on April 21, 2023, due to the recent FDA announcement.
NDC
Label Name
59267100001
Pfizer covid-19 vaccine-purple
59267100002
Pfizer covid-19 vaccine-purple
59267100003
Pfizer covid-19 vaccine-purple
80777027310
Moderna covid (12y up)vac(eua)
80777027315
Moderna covid (12y up)vac(eua)
80777027398
Moderna covid (12y up)vac(eua)
80777027399
Moderna covid (12y up)vac(eua)
80777027705
Moderna covid(6-11y) vacc(eua)
80777027799
Moderna covid(6-11y) vacc(eua)
80777027905
Moderna covid(6m-5y) vacc(eua)
80777027999
Moderna covid(6m-5y) vacc(eua)
Next steps for providers:
Providers should review the updated vaccination recommendations as it applies to members who:
originally received either of the monovalent Moderna or Pfizer-BioNTech COVID-19 vaccine
received any combination of monovalent and bivalent COVID-19 vaccines
are unvaccinated against COVID-19
Providers are encouraged to share this communication with their staff and to educate patients, our members.
